Having received CE Mark clearance, CardioInsight Technologies has launched its ecVUE System in Europe, and secured its first three clinical customers in England, Germany and France. CardioInsight’s patented ecVUE technology gathers electrical information from an electrode “vest” and combines the information with images from a CT scan to produce 3D “electrical maps” of the patient’s heart. To date, CardioInsight has completed more than 390 patient studies at leading clinical centers in the United States and Europe across a broad variety of cardiac arrhythmias, as well as CRT for congestive heart failures, demonstrating the unique clinical value of the ecVUE system, the results of which have been published in leading peer-reviewed journals. Learn more at www.cardioinsight.com.